Enhanced Recovery After Spine Surgery: A Systematic Review.

Enhanced recovery after surgery (ERAS) is a multidimensional approach to improving the care of surgical patients using subspecialty- and procedure-specific evidence-based protocols. The literature provides evidence of the benefits of ERAS implementation, which include expedited functional recovery, decreased postoperative morbidity, reduced costs, and improved subjective patient experience.

Continue reading
Topics:

Robot an Effective Pain Management Tool for Premature Babies

 

Researchers have designed a therapeutic robot that simulates human skin-to-skin contact, helping reduce pain for babies in the neonatal intensive care unit.

Continue reading
Topics:

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing.

Transmucosal immediate-release fentanyl (TIRF) drugs are potent, rapid-acting opioids approved to treat breakthrough pain in patients with cancer who are tolerant to other around-the-clock opioid analgesics. In March 201...
Continue reading
Topics:

NIH to Test Experimental Drug to Curb Opioid Cravings

A clinical trial of an experimental drug designed to treat cravings associated with OUD has begun in the National Institutes of Health Clinical Center. The Phase I trial in healthy adults will assess the safety of the experimental compound, ANS-6637, and how it is processed in the body when given with another drug that is processed by the same liver enzyme pathway. 

Continue reading
Topics:

HHS Releases Additional $487 Million to States, Territories to Expand Access to Effective Opioid Treatment; 2019 SOR Grants Will Total $1.4 Billion

 

This funding will expand access to treatment that works, especially to medication-assisted treatment (MAT) with appropriate social supports.

Continue reading
Topics:

Aegis Science Corporation Presents Corporate Showcase at AAPM35

View the 30-minute webinar : Are drug interactions harming your patients? Enhance DDI identification and patient care with Interact Rx™ Presented by Josh Schrecker, Pharm.D., Clinical Scientist, Healthcare Services, Aegi...
Continue reading
Topics:
DDI

Loratadine for Improvement of Bone Pain in Patients with Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use

G-CSF causes a release of histamine that may be a cause of chronic bone pain. Loratadine targets histamine, and so may be effective in reducing bone pain.The researchers plan to prospectively assess the effectiveness of loratadine for chronic bone pain in patients with chronic G-CSF use.

Continue reading

PCSS Discussion Forum: A Quick, Evidence-Based Resource from Clinical Experts

The PCSS Discussion Forum provides the opportunity for health professionals to discuss clinical practices around substance use disorders and opioid use disorder with colleagues and addiction and pain experts. (Sign up is required.) 

Continue reading
Topics:

A Clinical Overview of Off-label Use of Gabapentinoid Drugs

The gabapentinoid drugs gabapentin and pregabalin were originally developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For gabapentin, the only pain-related indication approved by the US Food and Drug Administration (FDA) is postherpetic neuralgia. For pregabalin, FDA-approved indications related to pain are limited to postherpetic neuralgia, neuropathic pain associated with diabetic neuropathy or spinal cord injury, and fibromyalgia.

Continue reading

Medications to Treat Opioid Addiction Are Effective and Save Lives, But Barriers Prevent Broad Access and Use, Says New Report

A new report from the National Academies of Sciences, Engineering and Medicine, Medications for Opioid Use Disorder Save Lives , says that withholding or failing to have available medications for the treatment of OUD in ...
Continue reading
Topics:

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More